AN
50
-5
DGX
48
11
KLAC
38
-6
DFS
64
2
PAYX
48
-6
EIX
70
3
IPG
34
-9
HIG
66
2
ABT
59
2
ALLE
37
-4
HCA
48
-2
A
37
-2
FOX
51
-6
ECL
55
-2
ISRG
71
-5
NEE
54
7
GE
61
-3
MTCH
20
-8
WM
74
-5
LH
40
-5
AN
50
-5
DGX
48
11
KLAC
38
-6
DFS
64
2
PAYX
48
-6
EIX
70
3
IPG
34
-9
HIG
66
2
ABT
59
2
ALLE
37
-4
HCA
48
-2
A
37
-2
FOX
51
-6
ECL
55
-2
ISRG
71
-5
NEE
54
7
GE
61
-3
MTCH
20
-8
WM
74
-5
LH
40
-5
Financhill
Back

Sarepta Therapeutics Vs. Neurogene Industry Stock Comparison

Sell
24

SRPT
Sarepta Therapeutics

Last Price:
104.56
Seasonality Move:
19.2%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
24
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $104.54. The Score for SRPT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $104.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.26 Sell
Relative Strength Index (14 RSI): 23.65 Sell
Chaikin Money Flow: -560985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (116.63 - 130.41) Sell
Bollinger Bands (100): (121.79 - 145.63) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.03 Sell
20-day SMA: 123.12 Sell
50-day SMA: 123.81 Sell
200-day SMA: 130.41 Sell
8-day EMA: 114.12 Sell
20-day EMA: 119.76 Sell
50-day EMA: 124.56 Sell
200-day EMA: 126.9 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):